nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Author index
|
|
|
2001 |
38 |
4 |
p. 393-395 3 p. |
artikel |
2 |
Cell culture and animal models to screen for promising fetal hemoglobin-stimulating compounds
|
Fibach, Eitan |
|
2001 |
38 |
4 |
p. 374-381 8 p. |
artikel |
3 |
Chelation therapy in β-thalassemia: An optimistic update
|
Giardina, Patricia J |
|
2001 |
38 |
4 |
p. 360-366 7 p. |
artikel |
4 |
Clinical management of β-Thalassemia major
|
Wonke, Beatrix |
|
2001 |
38 |
4 |
p. 350-359 10 p. |
artikel |
5 |
Erythrocyte-active agents and treatment of sickle cell disease
|
Brugnara, Carlo |
|
2001 |
38 |
4 |
p. 324-332 9 p. |
artikel |
6 |
Nitric oxide therapy in sickle cell disease
|
Gladwin, Mark T |
|
2001 |
38 |
4 |
p. 333-342 10 p. |
artikel |
7 |
Pathophysiology of α- and β-thalassemia: Therapeutic implications
|
Rund, Deborah |
|
2001 |
38 |
4 |
p. 343-349 7 p. |
artikel |
8 |
Pathophysiology of sickle cell disease: Role of cellular and genetic modifiers
|
Steinberg, Martin H |
|
2001 |
38 |
4 |
p. 299-306 8 p. |
artikel |
9 |
Pharmacological induction of fetal hemoglobin in sickle cell disease and β-thalassemia
|
Atweh, George F |
|
2001 |
38 |
4 |
p. 367-373 7 p. |
artikel |
10 |
Principles and problems of transfusion in sickle cell disease
|
Telen, Marilyn J |
|
2001 |
38 |
4 |
p. 315-323 9 p. |
artikel |
11 |
Sickle cell disease: Current clinical management
|
Ballas, Samir K |
|
2001 |
38 |
4 |
p. 307-314 8 p. |
artikel |
12 |
Subject index
|
|
|
2001 |
38 |
4 |
p. 395-435 41 p. |
artikel |
13 |
Toward gene therapy for disorders of globin synthesis
|
Tisdale, John |
|
2001 |
38 |
4 |
p. 382-392 11 p. |
artikel |